Here, we report that FBXO16 is overexpressed in ovarian cancer and has potent tumor-suppressive effect by targeting a heterogeneous nuclear ribonucleoprotein for ubiquitination dependent degradation. Here, FBXO16 is linked to ovarian carcinoma.